Intersect ENT is a US-based commercial stage drug-device company that specializes in providing therapeutic solutions for patients with ear, nose, and throat conditions. The company is known for its PROPEL and PROPEL mini drug releasing implants that are used to treat chronic sinusitis in patients undergoing sinus surgery. Intersect ENT is committed to improving the quality of life of patients by developing innovative technologies that address unmet medical needs in the ENT market.